Alpha-Rich Ideas
A $234 Million Company Worth $0: Short Biozoom
by Ashraf Eassa
Editor's notes: With no revenue and a shaky balance sheet, BIZM.OB is an attractive short. Tech expert Ashraf Eassa finds the company's technology is likely of limited value.
Pacific Biosciences Will Go Checkers Or Wreckers
by Stephen Simpson
Editor's notes: Looking beyond current cash burn, sector expert Stephen Simpson thinks PACB's genome-sequencing technology has 30% annual revenue growth potential. 38% discount to fair value.
Coinstar Shares Are Woefully Undervalued
by Money Investor
Editor's notes: CSTR continues to mint money, and the market has completely discounted the company's growth potential. With strong free cash flow and EBITDA growth leading the way, shares should follow.
Editors' Picks
FormFactor And The Changing Chip Market by Gary Bourgeault
Intel Broadwell Coming In 2014, 14 Nanometer On Track by Ashraf Eassa
ISIS Pharmaceuticals: Finally On Target After All These Years by John Tucker
Johnson & Johnson: Last 7 Years' Earnings More Than Previous 107 Years' by Robert Honeywill
Illegal Products Could Spell Big Trouble At Lumber Liquidators by Xuhua Zhou
How To Build A Generation 3 Tesla by John Bingham
Patent Juggernaut: The Damages Endgame by EDVA
Dominion Diamond Corporation Is A Finely Cut Diamond Selling Like An Ordinary Stone by Martin Vlcek
Time To Get Out Of Universal Technical Institute by Gary Bourgeault
Long Ideas
FormFactor And The Changing Chip Market by Gary Bourgeault
Amarin's Anchor Will Hold As Vascepa's Sails Unfurl by Michael Webb
Stryker: Smooth Sailing In Neurovascular Space by Amod Saul
Philip Morris: The Leading Tobacco Company by Equity Watch
Intel Broadwell Coming In 2014, 14 Nanometer On Track by Ashraf Eassa
Smith & Wesson Does Exactly What I Said It Would Do by Jacob Steinberg
Tree.com: A Classic Case Of Growth At A Reasonable Price by John Leonard
Solazyme: Primed To Succeed by Vikram Kumar
The Odds Favor Investors Of Dice Holdings by David Zanoni
Depressed Valuations For Alpha Natural Resources Offers An Attractive Opportunity by Equity Watch
OFG Bancorp Picks Up The Pace by Profit Fan
Calgon Carbon: Significant Earnings Growth Coming by Economics Fanatic
ISIS Pharmaceuticals: Finally On Target After All These Years by John Tucker
Older, Fatter Americans Will Enrich Edwards Lifesciences Corp by David McEwen
Why Every Long-Term Investor Should Own Wal-Mart Now by Morgan Myrmo
Pfizer/Zoetis: My Shares Are Not For Exchange - Or Are They? by Jim Osman
Ford Credit Is An Important Part Of Ford by Jacob Steinberg
Why Samsung's Market Share Gain Does Not Concern Me As An Apple Shareholder by AquaResearch
Men's Wearhouse's Competitive Advantage: High-Class Customer Service by Nikhil Raheja
Ryman Hospitality Offers A Big 5.4% Dividend But With Big Caveats by Gregory Vousvounis
Sorrento Has Multiple Shots On Goal, Worth A Closer Look by Tech Guru
Intel: The Next Unit Of Computing - NUC by Russ Fischer
Oncothyreon Might Be Worth It by Prescient Investment Analysis
The Right Time For Crosstex Energy by Energy Trade
On Track Innovations' Markman Gamble Pays Off by Markman Advisors
Advanced Micro Devices: The Chipmaker Of The Future? by Quinn Bredl
Johnson & Johnson: Last 7 Years' Earnings More Than Previous 107 Years' by Robert Honeywill
GameStop Rallies As Microsoft Capitulates On Used Game Policies by Trefis
Genpact: A Giant In The Arena Of Outsourcing by Neha Gupta
Nokia: Investors Are Getting The Device Division For Free At The Current Share Price by Genesis Housing
SolarCity Offers Compelling Risk/Reward Opportunity by Money Investor
Can United Insurance Holdings Double? by Jacob Steinberg
I Can Barely Contain Myself On This Red-Hot Small Cap by Bill Gunderson
Jinko Solar: Low Cost Solar Producer That Could Triple by Sneha Shah
Disney's Infinity Could Give New Life To Its Interactive Media Business by Trefis
What Are The Downside Risks For Facebook? by Trefis
Prescription For Your Portfolio: Teva Pharmaceuticals by Arnbjorn Ingimundarson
How To Build A Generation 3 Tesla by John Bingham
Vical And Astellas Pharma Initiate Phase III CMV Vaccine Study by Theodore Cohen
Bull Of The Day: Synchronoss Technologies by Zacks Investment Research
Why D. R. Horton Is The Top Candidate To Build On Housing Optimism by Troy Bayer
Cumulus Media And Its Growth Strategy by Gary Bourgeault
Mindray Medical: An In-Depth Look At A Healthcare Leader by Chris Katje
Bebe: A Turnaround In Progress, And A Rally Set To Continue by Helix Investment Research
Why Apple's Best Days Are Yet To Come by StockSaints
Boingo Wireless: Streaming Toward A Wireless - And More Profitable - Future by Helix Investment Research
Patent Juggernaut: The Damages Endgame by EDVA
Berkshire Hathaway: Utility Operations Brighten Berkshire's Bottom Line by Saibus Research
Here's An Italian Recovery Stock That Makes My 'Speculative' List by Bob Wilson
Monitise: A Pure Mobile Financial Services Play by Nathaniel Matherson
The SandRidge Energy Experience Reinforces The Importance Of Good Management by Devon Shire
Taminco: A Specialty Commodity Player by Investment Biker
Maxim Power - Hidden Asset Power Producer by Safety In Value
These 2 Automakers Stomp The Competition And Are Solid Investments by Mike the PhD
Pipeline Vs. Expiring Patents: Eli Lilly's Future by YCharts
Dominion Diamond Corporation Is A Finely Cut Diamond Selling Like An Ordinary Stone by Martin Vlcek
Sirius XM And Ford Expand Deal by Spencer Osborne
Healthcare Services Group: Yield With Growth Potential by Nathaniel Matherson
Political Risk Exposure For E&P Genel Energy by William M. Thomson
Hugoton Royalty Trust: Undervalued Against Current Natural Gas Futures by BermudaHigh
Peabody Energy Is Awaiting The Coal Market Rebound by Equity Watch
Game-Changing Merger Of MakerBot By Stratasys: Key Facts For 3D Print Investors by Richard Berger
Short Ideas
Amarin Is Dead With Or Without ANCHOR by The Specialist
Colfax Has Significant Downside: Overvalued, Debt-Laden And Huge Insider Sales by Ranjit Thomas
Illegal Products Could Spell Big Trouble At Lumber Liquidators by Xuhua Zhou
Guess: Overvalued And No Longer Fashionable by Jeffrey To
Time To Get Out Of Universal Technical Institute by Gary Bourgeault
Quick Picks & Lists
Kroger: Correction Offers Attractive Entry Point For This Well-Run Company by The Value Investor
1 Final Thought About The Pfizer-Zoetis Tender Offer by George Acs
2 Big-Name Biopharma Catalysts For Second Half 2013 by Brian L. Wilson
3 Stocks To Keep You Out Of The Sun by Zacks Investment Research
The State Of The Hepatitis C Pill Race: Gilead Vs. AbbVie by Peter Geschek
3 Reasons Why Verizon And AT&T Shares Should Be Sold Now by Hawkinvest
Five Below: Secondary Analysis by Nathaniel Matherson
Don't Be Fooled By The Fancy Name - Statistical Arbitrage Is A Simple Way To Profit by StreetAuthority
Find The Next Cooper Tire Or Berry Petroleum Takeover Targets by Marc Courtenay
Undervalued Stock Of The Week: Himax Technologies by Brad Kenagy
16 Large Caps That Bucked Yesterday's Fed-Inspired Sell-Off by Moby Waller
TripAdvisor Has Much Higher To Go by Intelligent Speculator
Knucklehead Buybacks: How To Find Smart Ones by YCharts
Cramer's Picks
Cramer's Mad Money - 5 Window Dressing Stocks Big Money May Buy Next Week (6/20/13) by SA Editor Miriam Metzinger
Cramer's Lightning Round - Go To The Source With Las Vegas Sands (6/20/13) by SA Editor Miriam Metzinger
Fund Holdings
One Year Later: 9 Rallying Stocks Under $5 Attracting Hedge Funds by Kapitall
Legendary Value Investors Love Google, But I Think It Is Fairly Valued At Best by Devon Shire
Insider Ownership
2 Tech Stocks With Recent Intensive Insider Selling by Markus Aarnio
IPO Analysis
IPO Preview: Gogo by IPOdesktop
Noodles & Co.: An IPO With Growth Potential by Pursuing Growth
IPO Preview: Votorantim Cimentos S.A. Postponed, Totally Mispriced by IPOdesktop
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario